Web show: Live tour of a global biotech firm’s highly rated intranet
IBF Live – the online broadcast featuring the best intranets from around the world
Digital Workplace Live is the unique online intranet show from IBF. Going out live on the first Tuesday of every month, it’s unmissable for anyone who works with intranets, portals and digital workplaces.
June 4th episode: Amgen’s highly rated intranet
On Tuesday, June 4th regular IBF Live hosts Paul Miller and Ephraim Freed welcome to the studio Laraine King and Edward Duque from Amgen for a live tour of the company’s highly rated and award-winning intranet.
Laraine King (@laraineking) is the company’s Corporate Communications Senior Manager, Web Strategy and Edward is a Specialist IS Business Systems Analyst. They are the core team behind Amgen’s intranet, named MyAmgen.
How to join the show
IBF Live is a paid service for Subscribers and IBF Members. Non-members can register for a one-time free guest pass to see this episode.
| What | IBF Live: Amgen’s highly rated intranet |
| When: | June 4th at 16-17:00 London-BST · 11-12:00 New York-EDT |
| Guests: | Guests can sign up for a one-time free guest pass. |
| Members: | Subscribers & DWG members will receive login details via email. |
(IBF Live Subscribers and IBF Members will have on-demand access to a full recording of the show on the private IBF extranet within 48 hours of the show’s conclusion.)
About Amgen’s intranet
The homepage of MyAmgen, Amgen’s intranet
Amgen is a member of the Digital Workplace Group (DWG) and has performed very well in recent benchmarking (what is intranet benchmarking?). See DWG’s Amgen case study for more information.
In 2011 the Amgen team won a PRism award from the Public Relations Association of America (PRSA) for its redesigned intranet.
This recognition is a clear statement of Amgen’s strong intranet programme and portends an excellent live intranet tour you won’t want to miss.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. It has been a leader in biotechnology since 1980 and today is a Fortune 500 company serving millions of patients.
Categorised in: Uncategorized
